Conferences

Catalog

Abstracts

Calendar

6th Binaytara Precision Oncology Summit: At The Forefront of Targeted Cancer Therapy

Accreditation: 10.00 AMA PRA Category 1 Credit™ | 10.00 ABIM MOC II | 10.00 Nursing Contact Hours | 10.00 ACPE Pharmacy

Venue: Hyatt Regency San Francisco Downtown SOMA, 50 3rd Street, San Francisco, CA, United States

Start Date: September 11End Date: September 12, 2026

Overview

Trusted by Thousands of Attendees
Across Our Events

32+

Email if you have questions

Our Speakers

Planning Committee

Binay Shah, MD, MHA

Conference Director

Binayatara

Mark Daniel Pegram, MD

Conference Co-Chair

Stanford University

James M. Ford, MD

Conference Co-Chair

Stanford University

Milana v Dolezal, MD

Associate Chair

Stanford School of Medicine

Sachdev P Thomas, MD

Associate Chair

Kaiser Permanente

Varun Monga, MD, MBBS

Associate Chair

University of California San Francisco

Milana v Dolezal, MD

Abstract Committee

Stanford School of Medicine

William Shomali, MD

Abstract Committee

Stanford University

Faculty

James M. Ford, MD

Session Chair

Stanford University

Vivek Subbiah, MD

Session Chair

Stanford Healthcare

Andreas Varkaris, MD, PhD

Session Chair

Massachusetts General Hospital

Arun Wiita, MD, PhD

Session Chair

University of California, San Francisco

Pamela Munster, MD

Session Chair

University of California San Francisco

Dennis Slamon, MD, PhD

Key Note Presenter

UCLA Medical Center

Bita Fakhri, MD, MPH

Topic Presenter

Daanish Ahmed

Topic Presenter

PrecisCa

Trever Bivona, MD, PhD

Topic Presenter

UCSF

Pedram Razavi, MD PhD

Topic Presenter

Memorial Sloan Kettering Cancer Center

James Brugarolas, MD, MD

Topic Presenter

UT Southwestern Medical Center

Nancy Lin, MD

Topic Presenter

Dana-Farber Cancer Institute

Kayla Haines, MSN, MSN, APRN, APRN, FNP-C, FNP-C

Topic Presenter

PrecisCa

Melinda L. Telli, MD

Topic Presenter

Stanford Health Care

Siddhartha Yadav, MD

Topic Presenter

Mayo Clinic

Judith A. Varner, PhD

Topic Presenter

University of California, San Diego Moores Cancer Center

Byron Aram, MD

Topic Presenter

EosDx Inc.

Naoto Ueno, MD, PhD, FACP

Topic Presenter

University of Hawai'i Cancer Center

Andrei Iagaru, MD

Topic Presenter

Stanford Health Care

Ignacio Rose Garrido-Laguna, MD, MBA, PhD

Topic Presenter

H. Lee Moffitt Cancer Center & Research Institute

Mark Daniel Pegram, MD

Topic Presenter

Stanford University

Steven M Corsello, MD

Topic Presenter

Department of Medicine - Med/Oncology, Stanford Health Care, Stanford, CA, USA

James Zou, PhD

Topic Presenter

stanford university

Elizabeth O' Donnell, MD

Topic Presenter

Dana Farber Cancer Institute

Our Agenda

Day 1: Friday, September 11th, 2026

All timings are in Pacific Time (PDT, GMT-07:00) time.

09:00 AM - 10:00 AMRegistration, Breakfast, & Exhibits

10:00 AM - 10:30 AMSession 1: Key Note Address

10:00 AM - 10:30 AM

Target Discovery and Validation – Dennis Slamon, MD, PhD

10:30 AM - 11:45 AM Session 2: Germline Alterations in Human Cancers

Session Chair: Pamela Munster, MD

10:30 AM - 10:45 AM

Overview of germline vs. somatic mutations in cancer predisposition - Role in therapy selection across tumor types – Siddhartha Yadav, MD

10:45 AM - 11:00 AM

Current targeted therapies for germline alterations in Breast Cancer – Melinda L. Telli, MD

11:00 AM - 11:15 AM

Future Pipeline Agents Targeting Germline DNA alterations in Cancer Medicine – Pamela Munster, MD

11:15 AM - 11:30 AM

An Academic Journey from Gene Discovery to First-in-Class FDA Approval for Familial and Sporadic Kidney Cancer – James Brugarolas, MD, MD

11:30 AM - 11:45 AM

Panel Discussion

Moderators:

Pamela Munster, MD

Panelists:

Siddhartha Yadav, MD; Melinda L. Telli, MD; James Brugarolas, MD, MD

11:45 AM - 01:00 PMSession 3: Molecular Diagnostics in Precision Oncology

Session Chair: James M. Ford, MD

11:45 AM - 12:00 PM

NHS-Galleri Trial – Elizabeth O' Donnell, MD

12:00 PM - 12:15 PM

Sensitive Detection of MRD in Early-stage Cancer – Milana v Dolezal, MD

12:15 PM - 12:30 PM

Controversies in Treatment-emergent Drug Resistance Mutations: Intervention Prior to RECIST Disease Progression – Pedram Razavi, MD PhD

12:30 PM - 01:00 PM

Panel Discussion

Moderators:

James M. Ford, MD

Panelists:

Elizabeth O' Donnell, MD; Milana v Dolezal, MD; Pedram Razavi, MD PhD

01:00 PM - 02:00 PMLunch & Exhibits

01:00 PM - 01:45 PMResearch Poster Presentation

02:00 PM - 03:00 PMAntibody-based Therapeutics

Session Chair: Arun Wiita, MD, PhD

02:00 PM - 02:15 PM

Novel ADC Linker/Payload Considerations – Mark Daniel Pegram, MD

02:15 PM - 02:30 PM

Therapeutic strategies targeting brain metastases – Nancy Lin, MD

02:30 PM - 03:00 PM

Panel Discussion

03:00 PM - 03:20 PMBreak & Exhibits

03:20 PM - 04:20 PMMolecular Tumor Board 1: Interesting and Challenging Cases in Precision Oncology

Session Chair: James M. Ford, MD

04:20 PM - 05:35 PMDrug Resistance in Precision Oncology

Session Chair: Vivek Subbiah, MD

04:20 PM - 04:35 PM

Adaptive Feedback and Bypass Pathways – Trever Bivona, MD, PhD

04:35 PM - 04:50 PM

Mechanisms of ADC Resistance – Naoto Ueno, MD, PhD, FACP

04:50 PM - 05:05 PM

Tumor Microenvironment Role – Judith A. Varner, PhD

05:05 PM - 05:35 PM

Panel Discussion

05:35 PM - 05:35 PMAdjourn Day 1

Day 2: Saturday, September 12th, 2026

07:00 AM - 08:00 AMRegistration, Breakfast & Exhibits

About 6th Binaytara Precision Oncology Summit: At The Forefront of Targeted Cancer Therapy

Overview

Faculty and committee

Our Speakers

Planning Committee

Faculty

Conference program and agenda

Our Agenda

Venue and map

Accreditations and continuing education

Registration and pricing

Exhibitors and sponsorship